Data / Drug companies / Menper Distributors, Inc.
Menper Distributors, Inc.: 39 products in the FDA NDC directory, labeler code 53145
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Menper Distributors, Inc. (labeler code 53145) lists 39 products in the FDA National Drug Code Directory, covering 25 finished drugs by generic name. By type: 39 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 1, 2026.
The request: Watch Menper Distributors, Inc. (FDA labeler code 53145): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53145
- Products in commercial distribution
- 39
- Packages
- 43
- Finished drugs by generic name
- 25
- Prescription products
- 0
- Over the counter products
- 39
- Flagged as original packager
- 39 of 39 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- January 18, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 39 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 39 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Methyl salicylate | 5 | 24 |
| Undecylenic acid | 3 | 38 |
| Acetaminophen | 3 | 214 |
| Dextromethorphan hbr, guaifenesin, phenylephrine hcl | 2 | 28 |
| Guaifenesin, dextromethorphan | 2 | 1 |
| Sodium bicarbonate | 2 | 51 |
| Acetaminophen, diphenhydramine hcl, phenylephrine hci | 1 | 1 |
| Pyrethrum extract, piperonyl butoxide | 1 | 1 |
| Bismuth subsalicylate | 1 | 80 |
| Guaifenesin, dextromethorphan hbr | 1 | 26 |
| Camphor, menthol, eucalyptus oil | 1 | 12 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Pyrantel pamoate | 1 | 13 |
| Dextromethorphan hydrobromide, guaifenesin | 1 | 49 |
| Dextromethorphan, guiafenesin, phenylephrine | 1 | 1 |
| Dextromethorphan, guaifenesin | 1 | 5 |
| Undecylenic acid, zinc undecylenate | 1 | 1 |
| Phenol | 1 | 31 |
| Benzocaine | 1 | 110 |
| Carbamide peroxide | 1 | 37 |
| Magnesium sulfate heptahydrate | 1 | 20 |
| Menthol | 1 | 263 |
| Neomycin sulfate | 1 | 12 |
| Acetaminophen, chlorpherinamine maleate, phenylephrine hci | 1 | 1 |
| Dextromethorphan hbr, phenylephrine hcl | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 19 | 48.7% |
| Ointment | 6 | 15.4% |
| Tablet | 4 | 10.3% |
| Spray | 3 | 7.7% |
| Shampoo | 1 | 2.6% |
| Suspension | 1 | 2.6% |
| Solution | 1 | 2.6% |
| Oil | 1 | 2.6% |
| Powder | 1 | 2.6% |
| Crystal | 1 | 2.6% |
| Gel | 1 | 2.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Duralgina Extra Strength | 53145-830 | Tablet | Over the counter monograph drugs | June 1, 2026 |
| BeeVenom | 53145-315 | Ointment | Over the counter monograph drugs | April 1, 2026 |
| Sal Inglesa EPSOM SALT | 53145-580 | Crystal | Over the counter monograph drugs | July 1, 2025 |
| Adult Bisolvine Adult | 53145-323 | Liquid | Over the counter monograph drugs | May 1, 2025 |
| Mucosan Severe Multi-Symptom | 53145-697 | Liquid | Over the counter monograph drugs | November 1, 2024 |
| Mucosan Max with Acetaminophen | 53145-696 | Liquid | Over the counter monograph drugs | November 1, 2024 |
| Mucosan Multi-Symptom Honey | 53145-695 | Liquid | Over the counter monograph drugs | November 1, 2024 |
| Mucosan Multi-Symptom Cherry | 53145-693 | Liquid | Over the counter monograph drugs | November 1, 2024 |
| Mucosan Childrens Multi-Symptom Grape | 53145-691 | Liquid | Over the counter monograph drugs | November 1, 2024 |
| Viva Porru Chest Rub | 53145-707 | Ointment | Over the counter monograph drugs | January 1, 2024 |
| Defensol D Blister Pack | 53145-009 | Tablet | Over the counter monograph drugs | January 1, 2024 |
| Bismutina | 53145-475 | Liquid | Over the counter monograph drugs | April 1, 2021 |
| Abejas y Viboras Roll On | 53145-705 | Liquid | Over the counter monograph drugs | March 31, 2021 |
| Hongocura S | 53145-319 | Spray | Over the counter monograph drugs | April 6, 2020 |
| Hongocura M | 53145-219 | Spray | Over the counter monograph drugs | April 6, 2020 |
| Berro y Cebolla DM | 53145-080 | Liquid | Over the counter monograph drugs | April 1, 2019 |
| Bisolvine Aloe-Miel | 53145-402 | Liquid | Over the counter monograph drugs | January 1, 2019 |
| Hongocura | 53145-017 | Ointment | Over the counter monograph drugs | October 9, 2018 |
| Sodium Bicarbonate Antacid | 53145-390 | Powder | Over the counter monograph drugs | January 1, 2017 |
| Duralgina | 53145-013 | Tablet | Over the counter monograph drugs | January 1, 2017 |
| Defensol-ito | 53145-333 | Solution | Over the counter monograph drugs | January 1, 2014 |
| Auralyt | 53145-311 | Liquid | Over the counter monograph drugs | January 1, 2014 |
| Anestenka | 53145-301 | Liquid | Over the counter monograph drugs | January 1, 2014 |
| Liendrex | 53145-308 | Shampoo | Over the counter monograph drugs | January 1, 2013 |
| Parasitol | 53145-101 | Suspension | Over the counter monograph drugs | January 1, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.